| Description | Catumaxomab, a trifunctional IgG2 antibody with mouse and rat heavy and light chain components, targets human EpCAM and CD3 receptors. Its Fc region exhibits affinity for FcγRI (CD64), FcγRIIA (CD32a), and FcγRIII (CD16), making it a valuable tool in epithelial cancer anti-tumor research [1] [2]. |
| In vitro | Catumaxomab（0-5 ng/mL；3-7天）对与PBMC共培养的FaDu肿瘤球体显示出剂量依赖性的显著生长抑制效应[2]。 |
| molecular weight | N/A |
| CAS | 509077-98-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years | Shipping with blue ice. |